Hi Martinoh
my opinion;
-very competitive market (3 wholesalers plus new entrants)
-Pfizer gone direct (bypassing CSO model), Astra doing same with some products, any more considering same?
-dependent upon Govt CSO margin
- history of Senior Execs turnover (compare last 3-4 years annual report)
-Reliance upon Chemist Warehouse
-PBS reforms driving profitability down
-increased business due to aging population off set by lower PBS prices?
-dividend stock more so than growth stock?
-prefer someone like CSL
- Forums
- ASX - By Stock
- SIG
- Ann: CEO Address to Shareholders
Ann: CEO Address to Shareholders, page-9
Add SIG (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.78 |
Change
0.080(2.96%) |
Mkt cap ! $2.300B |
Open | High | Low | Value | Volume |
$2.74 | $2.93 | $2.74 | $37.80M | 13.25M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 167207 | $2.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.79 | 246261 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 218946 | 0.530 |
12 | 254849 | 0.525 |
22 | 667773 | 0.520 |
12 | 214898 | 0.515 |
31 | 592381 | 0.510 |
Price($) | Vol. | No. |
---|---|---|
0.535 | 238324 | 12 |
0.540 | 239570 | 11 |
0.545 | 263300 | 10 |
0.550 | 155978 | 9 |
0.555 | 81292 | 5 |
Last trade - 16.10pm 28/11/2024 (20 minute delay) ? |
SIG (ASX) Chart |